Eikon Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2025 | — | — | $204.6M |
| Jun 2025 | — | — | $136.6M |
| Dec 2025 | $312.3M | $594.7M | $104.9M |
| Mar 2026 | $300.2M | $850.8M | $161.2M |
| Jun 2026 | $313.1M | $779.6M | $142.6M |
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2025 | — | — | $204.6M |
| Jun 2025 | — | — | $136.6M |
| Dec 2025 | $312.3M | $594.7M | $104.9M |
| Mar 2026 | $300.2M | $850.8M | $161.2M |
| Jun 2026 | $313.1M | $779.6M | $142.6M |